Trial Profile
Prospective Observational Study to Evaluate Persistence With Prolia (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Amgen
- 09 Feb 2016 New trial record